Here are relevant reports on : ms-polymer-sealants-market
-
Epigenetics Market by Product (Kit [Antibodies, Reagents], Enzyme), Service (Single-Cell Epigenomics, Multi-omics), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR, MS), Application (Oncology, Immunology, CVD) - Global Forecast to 2031
The global epigenetics market is projected to reach USD 3.92 billion by 2031, growing at a CAGR of 12.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution), Application (F&B, Environmental, Pharma, Clinical Diagnostic, Forensics), Region - Global Forecast to 2030
The global analytical standards market, valued at US$1.44 billion in 2022, stood at US$1.53 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$2.16 billion by the end of the period. The key factors driving the market growth include the stringent regulatory guidelines in the pharmaceutical industry; increasing public-private investments for research projects; the rising public concerns about food safety & quality; and the growing applications of analytical techniques in proteomics and metabolomics.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Reaction Monitoring Market by Technology (Spectroscopy (MS, IR, UV, NMR, Raman), Chromatography (GC, LC), Calorimetry, Titrimetry, XRD), Mode (Quantitative, Qualitative), End User (Research, Pharma-Biotech, Food & Beverages Co) - Global Forecasts to 2022
The global reaction monitoring market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%. Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and increasing public-private investments in life science research are driving the reaction monitoring market. The major players in the market are Agilent (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US) , and HORIBA (Japan).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
North America Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)-Forecast to 2030
The North America biomarkers Market, valued at US$23.35 billion in 2024, stood at US$25.13 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$45.25 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Trace Metal Analysis Market by Technology Instrument (Atomic Absorption Spectroscopy, X-Ray Fluorescence, ICP-MS), Service (FAAS, ICP-OES)), Application (Food & Beverage, Pharmaceutical & Biotechnology, Environmental Testing) - Global Forecast to 2024
The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines. Prominent players in the trace metal analysis market are Thermo Fisher Scientific (US), Agilent Technologies (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market by Modality (Spectroscopy: Raman, IR, NMR; Chromatography: HPLC, GC; MS, qPCR, NGS), Product (Analyzer, Sensor, Software), Mode (Online, At-line), Application (Biologics, CGT)- Global Forecast to 2031
The global biopharmaceutical process analytical technology market is projected to reach USD 4.32 billion by 2031, growing at a CAGR of 17.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Mass Spectrometry Market by Product [Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software, Services], Inlet Type (LC-MS, GC-MS, ICP-MS, Other Inlet Types), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecast to 2031
The global mass spectrometry market is projected to reach USD 10.78 billion by 2031, growing at a CAGR of 8.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Rapid Test Market (Services) by Technology (PCR, Immunoassay, HPLC, GC-MS, LC-MS/MS), Contaminant (Pathogens, Meat speciation, GMO, Allergens, Pesticides, Mycotoxin, Heavy Metals), Food Tested (Processed, Crops), and Region - Global Forecast to 2022
The rapid test market, in terms of value, was valued at USD 10.14 Billion in 2016. It is projected to reach USD 15.71 Billion by 2022, at a CAGR of 7.7% from 2017. This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. More than 240 developments were tracked for the 25 companies in the market. It includes the profiles of leading companies such as SGS (Switzerland), Bureau Veritas (France), Intertek (UK), Eurofins (Luxembourg), and TUV SUD (Germany).
- Published: September 2017
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
